[go: up one dir, main page]

DE602004006443D1 - Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung - Google Patents

Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung

Info

Publication number
DE602004006443D1
DE602004006443D1 DE602004006443T DE602004006443T DE602004006443D1 DE 602004006443 D1 DE602004006443 D1 DE 602004006443D1 DE 602004006443 T DE602004006443 T DE 602004006443T DE 602004006443 T DE602004006443 T DE 602004006443T DE 602004006443 D1 DE602004006443 D1 DE 602004006443D1
Authority
DE
Germany
Prior art keywords
extended release
faxinhydrochloride
vena
vaccines
coated mini
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004006443T
Other languages
English (en)
Other versions
DE602004006443T2 (de
Inventor
Sampad Bhattacharya
Rajesh Kshirsagar
Mayank Joshi
Sandeep Pandita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alembic Ltd
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of DE602004006443D1 publication Critical patent/DE602004006443D1/de
Application granted granted Critical
Publication of DE602004006443T2 publication Critical patent/DE602004006443T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602004006443T 2004-02-04 2004-10-27 Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung Expired - Fee Related DE602004006443T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
INMU01172004 2004-02-04
IN117MU2004 2004-02-04
IN980MU2004 2004-09-13
INMU09802004 2004-09-13
PCT/IN2004/000340 WO2005074895A1 (en) 2004-02-04 2004-10-27 Extended release coated microtablets of venlafaxine hydrochloride

Publications (2)

Publication Number Publication Date
DE602004006443D1 true DE602004006443D1 (de) 2007-06-21
DE602004006443T2 DE602004006443T2 (de) 2008-01-10

Family

ID=34809925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004006443T Expired - Fee Related DE602004006443T2 (de) 2004-02-04 2004-10-27 Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung

Country Status (22)

Country Link
US (1) US7807195B2 (de)
EP (1) EP1711169B1 (de)
JP (1) JP2007520547A (de)
AT (1) ATE361743T1 (de)
AU (1) AU2004315136B2 (de)
BR (1) BRPI0418283A (de)
CA (1) CA2555295C (de)
CY (1) CY1106741T1 (de)
DE (1) DE602004006443T2 (de)
DK (1) DK1711169T3 (de)
ES (1) ES2287813T3 (de)
HR (1) HRP20070353T3 (de)
IL (1) IL177243A0 (de)
MX (1) MXPA06008854A (de)
NO (1) NO20063809L (de)
NZ (1) NZ548504A (de)
PL (1) PL1711169T3 (de)
PT (1) PT1711169E (de)
RU (1) RU2340331C2 (de)
SI (1) SI1711169T1 (de)
UA (1) UA82597C2 (de)
WO (1) WO2005074895A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
PL377473A1 (pl) * 2002-11-28 2006-02-06 Themis Laboratories Private Limited Sposób produkcji mikropeletek o przedłużonym uwalnianiu zawierających chlorowodorek wenlafaksyny
WO2006136927A1 (en) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Extended release formulations comprising venlafaxine
EP1906935A4 (de) * 2005-07-28 2010-10-20 Reddys Lab Ltd Dr Venlafaxin-zusammensetzungen mit verlängerter freisetzung
WO2007102169A1 (en) * 2006-03-08 2007-09-13 Jubilant Organosys Limited Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
EP2010162A4 (de) * 2006-04-03 2013-01-09 Isa Odidi Zusammensetzung zur abgabe eines arzneimittels
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
EP2561877A1 (de) * 2006-12-20 2013-02-27 Mylan Pharmaceuticals ULC Zusammensetzung mit Biphosphonsäure in Kombination mit Vitamin D
US20100120723A1 (en) * 2006-12-20 2010-05-13 Mostafa Akbarieh Pharmaceutical composition comprising a hot-melt granulated lubricant
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) * 2008-12-10 2010-06-30 上海复星普适医药科技有限公司 文拉法辛缓释制剂的制备方法
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
CA2826180C (en) 2011-01-31 2020-09-01 Serotech, Llc Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
WO2017111005A1 (ja) 2015-12-25 2017-06-29 富山化学工業株式会社 １－（３－（２－（１－ベンゾチオフェン－５－イル）エトキシ）プロピル）アゼチジン－３－オールまたはその塩を含む錠剤

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
WO1999059573A1 (en) * 1998-05-15 1999-11-25 Warner-Lambert Company Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
CA2389568A1 (en) 1999-11-22 2001-05-31 Alza Corporation Osmotic dosage form comprising first and second coats
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) * 2000-05-31 2002-02-26 Pharma Pass Llc Tablet comprising a delayed release coating
WO2002085335A1 (en) * 2001-04-18 2002-10-31 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
WO2003053402A1 (en) 2001-12-20 2003-07-03 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003103637A2 (en) * 2002-01-10 2003-12-18 Ranbaxy Laboratories Limited Modified release, multiple unit drug delivery systems
EP1487429A2 (de) * 2002-03-28 2004-12-22 Synthon B.V. Zusammensetzungen von venlafaxin-grundlage
AR039164A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7058999B2 (en) * 2002-10-24 2006-06-13 Paramount Bed Co., Ltd. Electric bed and control apparatus and control method therefor
WO2004037226A2 (en) * 2002-10-25 2004-05-06 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions containing venlafaxine
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
EP1596837A2 (de) * 2003-02-07 2005-11-23 Omega Farma Ehf Venlafaxin-formulierungen mit verzogerter freisetzung
PT1502587E (pt) * 2003-07-30 2007-01-31 Pharmathen Sa Formulação de libertação prolongada para cloridrato de venlafaxina
US7016014B2 (en) * 2004-02-27 2006-03-21 Asml Netherlands B.V Lithographic apparatus and device manufacturing method

Also Published As

Publication number Publication date
MXPA06008854A (es) 2007-01-23
NZ548504A (en) 2009-03-31
US7807195B2 (en) 2010-10-05
KR20070000439A (ko) 2007-01-02
DE602004006443T2 (de) 2008-01-10
CA2555295A1 (en) 2005-08-18
HK1091137A1 (en) 2007-01-12
US20050169985A1 (en) 2005-08-04
DK1711169T3 (da) 2007-09-17
UA82597C2 (uk) 2008-04-25
ATE361743T1 (de) 2007-06-15
PT1711169E (pt) 2007-07-23
WO2005074895A1 (en) 2005-08-18
CA2555295C (en) 2011-01-18
AU2004315136A1 (en) 2005-08-18
IL177243A0 (en) 2006-12-10
SI1711169T1 (sl) 2007-10-31
NO20063809L (no) 2006-08-25
AU2004315136B2 (en) 2010-06-17
HRP20070353T3 (en) 2008-01-31
CY1106741T1 (el) 2012-05-23
PL1711169T3 (pl) 2007-10-31
EP1711169A1 (de) 2006-10-18
EP1711169B1 (de) 2007-05-09
JP2007520547A (ja) 2007-07-26
RU2006129034A (ru) 2008-03-10
ES2287813T3 (es) 2007-12-16
BRPI0418283A (pt) 2007-05-02
RU2340331C2 (ru) 2008-12-10

Similar Documents

Publication Publication Date Title
CY1106741T1 (el) Επικαλυμμενα μινι-δισκια παρατεταμενης αποδεσμευσης υδροχλωρικης βενλαφαξινης
AP2012006231A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
WO2008027557A3 (en) Topiramate compositions and methods of enhancing its bioavailability
ECSP077238A (es) Composiciones para entrega de drogas altamente solubles en agua
CR8102A (es) Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa
ATE496021T1 (de) Kristalline formen von (-)-(1r,2r)-3-(3- dimethylamino-1-ethyl-2-methylpropyl)- phenolhydrochlorid zur verwendung als aktivstoff in pharmazeutischen zubereitungen
EP1513825A4 (de) Antituberkulöses arzneimittel: zusammensetzungen und verfahren
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
EA200602137A1 (ru) Гидрогелевые препараты интерферона
BRPI0516577A (pt) agentes terapêuticos com toxicidade diminuìda
MX341015B (es) Forma de dosificacion de liberacion extendida.
ATE442158T1 (de) Oral verabreichte pharmazeutische zusammensetzungen mit einem abgabemittel in mikronisierter form
SG152257A1 (en) Topical preparation containing ambroxol
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
WO2004010972A3 (en) Pellicle-resistant gelatin capsule
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
WO2005107709A3 (en) Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
TNSN06242A1 (en) Extended release coated minitablets of venlafaxine hydrochloride
DE602006012962D1 (de) Pharmazeutische Zubereitungen von Ciprofloxacin
NO20065791L (no) Asyklovir-formuleringer
TW200716114A (en) Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
BRPI0508111A (pt) composições farmacêuticas secas por aspersão
MX2009006735A (es) Capsulas de gelatina que comprenden un acido.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee